Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 May;163(1):116-24.
doi: 10.1111/j.1476-5381.2010.01198.x.

Cough: an unmet clinical need

Affiliations
Review

Cough: an unmet clinical need

Peter V Dicpinigaitis. Br J Pharmacol. 2011 May.

Abstract

Cough is among the most common complaints for which patients worldwide seek medical attention. Thus, the evaluation and treatment of cough result in tremendous financial expenditure and consumption of health care resources. Yet, despite the clinical significance of cough, research efforts aimed at improving diagnostic capabilities and developing more effective therapeutic agents have been, to date, disappointing in their limited scope and outcomes. Acute cough due to the common cold represents the most common type of cough. Currently, available medications for the symptomatic management of acute cough are inadequate due to lack of proven efficacy and/or their association with undesirable or intolerable side effects at anti-tussive doses. Subacute cough, often representing a prolonged post-viral response, is typically refractory to standard anti-tussive therapy. Few clinical trials have evaluated therapeutic options for subacute cough. Diagnostic challenges facing the clinician in the management of chronic cough include the determination of whether symptoms of upper airway cough syndrome (formerly, postnasal drip syndrome) or gastro-oesophageal reflux disease are indeed the underlying cause of cough. Chronic, refractory unexplained (formerly, idiopathic) cough must be distinguished from cough that has not been fully evaluated and treated according to current guideline recommendations. Eagerly awaited are new safe and effective anti-tussive agents for use when cough suppression is desired, regardless of underlying aetiology of cough, as well as practical, validated ambulatory cough counters to aid clinical assessment and future research in the field of cough.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Potential mechanisms linking gastro-oesophageal reflux events and cough (reprinted with permission from Smith et al., 2010a).

Similar articles

  • Clinical perspective - cough: an unmet need.
    Dicpinigaitis PV. Dicpinigaitis PV. Curr Opin Pharmacol. 2015 Jun;22:24-8. doi: 10.1016/j.coph.2015.03.001. Epub 2015 Mar 13. Curr Opin Pharmacol. 2015. PMID: 25771118 Review.
  • Pharmacologic therapy for cough.
    Young EC, Smith JA. Young EC, et al. Curr Opin Pharmacol. 2011 Jun;11(3):224-30. doi: 10.1016/j.coph.2011.06.003. Epub 2011 Jul 1. Curr Opin Pharmacol. 2011. PMID: 21724464
  • Currently available antitussives.
    Dicpinigaitis PV. Dicpinigaitis PV. Pulm Pharmacol Ther. 2009 Apr;22(2):148-51. doi: 10.1016/j.pupt.2008.08.002. Epub 2008 Aug 19. Pulm Pharmacol Ther. 2009. PMID: 18771744 Review.
  • Developing antitussives: the ideal clinical trial.
    Birring SS. Birring SS. Pulm Pharmacol Ther. 2009 Apr;22(2):155-8. doi: 10.1016/j.pupt.2008.10.012. Epub 2008 Nov 13. Pulm Pharmacol Ther. 2009. PMID: 19041729 Review.
  • Potential new cough therapies.
    Dicpinigaitis PV. Dicpinigaitis PV. Pulm Pharmacol Ther. 2004;17(6):459-62. doi: 10.1016/j.pupt.2004.09.010. Pulm Pharmacol Ther. 2004. PMID: 15564092 Review.

Cited by

References

    1. Adcock JJ. TRPV1 receptors in sensitisation of cough and pain reflexes. Pulm Pharmacol Ther. 2009;22:65–70. - PubMed
    1. Bajbouj M, Becker V, Neuber M, Schmid RM, Meining A. Combined ph-metry/impedance monitoring increases the diagnostic yield in patients with atypical gastroesophageal reflux symptoms. Digestion. 2007;76:223–228. - PubMed
    1. Bangalore S, Kumar S, Messerli FH. Angiotensin-converting enzyme inhibitor associated cough: deceptive information from the Physicians' Desk Reference. Am J Med. 2010;123:1016–1030. - PubMed
    1. Berry MA, Hargadon B, McKenna S, Shaw D, Green RH, Brightling CE, et al. Observational study of the natural history of eosinophilic bronchitis. Clin Exp Allergy. 2005;35:598–601. - PubMed
    1. Berthet S, Charpiat B, Mabrut JY. Erythromycin as a prokinetic agent: risk factors. J Visc Surg. 2010;147:e13–e18. - PubMed

Substances